KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Liabilities and Shareholders Equity (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $199.2 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 10.61% to $199.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $779.1 billion through Dec 2025, up 9.51% year-over-year, with the annual reading at $199.2 billion for FY2025, 10.61% up from the prior year.
  • Liabilities and Shareholders Equity hit $199.2 billion in Q4 2025 for Johnson & Johnson, up from $192.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $199.2 billion in Q4 2025 to a low of $166.1 billion in Q4 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $181.7 billion across 5 years, with a median of $179.2 billion in 2021.
  • Biggest five-year swings in Liabilities and Shareholders Equity: fell 12.25% in 2024 and later rose 12.62% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $179.2 billion in 2021, then fell by 2.29% to $175.1 billion in 2022, then fell by 4.32% to $167.6 billion in 2023, then rose by 7.49% to $180.1 billion in 2024, then rose by 10.61% to $199.2 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for JNJ at $199.2 billion in Q4 2025, $192.8 billion in Q3 2025, and $193.4 billion in Q2 2025.